CNS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.215 USD | +5.39% |
|
+6.44% | -83.07% |
| 04-23 | Transcript : CNS Pharmaceuticals, Inc. - Special Call | |
| 04-01 | CNS Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar CNS Pharmaceuticals, Inc.
065bd5f5.h3oF9aUbeVeTs3_rgWC-MiNIZkQcQBTl1wAqV4tfMtU.wRRWmfwjEDCq6hWc4jf9fE09CAFqMX-rm2tvY9RmZe3vMXyhlW0wIfLqGA~e41e80dfde8cf32dc2e27a547613840c
Upcoming events on CNS Pharmaceuticals, Inc.
Past events on CNS Pharmaceuticals, Inc.
| 2024-04-09 13:00 | LD Micro Invitational Conference |
| 2024-04-04 16:25 | MedInvest Biotech & Pharma Investor Conference |
| 2023-11-15 08:00 | Q3 2023 Earnings Release |
| 2023-11-14 | Society of NeuroOncology Meeting |
| 2023-10-24 16:00 | Ask The CEO Virtual Investor Conference |
| 2023-09-14 15:00 | Annual General Meeting |
| 2023-09-13 10:30 | H.C. Wainwright Global Investment Conference |
| 2023-08-14 07:35 | Q2 2023 Earnings Release |
| 2023-08-10 20:30 | SNO/ASCO CNS Cancer Conference - Abstract Code: TIPS-20 |
| 2023-08-03 11:35 | Benzinga Virtual Biotech Conference |
| 2023-07-11 12:00 | Virtual Investor Summer Spotlight Conference |
| 2023-06-21 14:30 | Maxim Group Virtual Healthcare Conference |
| 2023-05-15 08:35 | Q1 2023 Earnings Release |
| 2023-05-03 12:00 | Virtual Investor Spotlight Conference |
| 2023-04-04 15:00 | Investor Meeting - Key Opinion Leader |
| 2023-04-03 08:05 | Q4 2022 Earnings Release |
| 2023-01-18 10:00 | Virtual Investor Conference |
| 2022-12-06 11:00 | Ask the CEO Virtual Investor Conference |
| 2022-11-14 16:05 | Q3 2022 Earnings Release |
| 2022-09-28 13:00 | Oncology Spotlight Featuring CNS Pharmaceuticals Virtual Investor Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -3,83 -1,40 -173.78% | -9,45 -8,51 -11.06% | -14,0 -15,7 10.51% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,88 -1,50 -158.48% | -9,46 -8,51 -11.1% | -14,0 -15,7 10.5% |
|
Net income Million USD | Released Forecast Spread | -3,88 -1,50 -158.48% | -9,46 -8,51 -11.1% | -14,0 -15,7 10.5% |
|
EPS USD | Released Forecast Spread | -8,40 -3,30 -154.55% | -17,1 -15,1 -13.43% | -15,9 -17,9 10.92% |
| Announcement Date | 12/03/20 | 12/02/21 | 03/03/22 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2023 Q2 | 2023 Q3 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | |
|
EBIT Million USD | Released Forecast Spread | -2,79 -4,44 37.11% | -2,78 -4,24 34.39% | -3,56 -3,15 -13.19% | -3,42 -3,85 11.29% | -4,03 -5,38 25.14% | -4,53 -5,89 23.02% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,80 -4,44 37.07% | -2,78 -4,24 34.33% | -3,57 -3,15 -13.24% | -3,42 -3,85 11.27% | -4,02 -5,38 25.21% | -4,52 -5,89 23.21% |
|
Net income Million USD | Released Forecast Spread | -2,80 -4,44 37.07% | -2,78 -4,24 34.33% | -3,57 -3,15 -13.24% | -3,42 -3,85 11.27% | -4,02 -5,38 25.21% | -4,52 -5,89 23.21% |
|
EPS USD | Released Forecast Spread | -3,00 -4,80 37.5% | -2,10 -3,30 36.36% | -2,70 -2,40 -12.5% | -2,70 -3,00 10% | -1,04 -2,82 63.12% | -1,08 -1,73 37.57% |
| Announcement Date | 03/03/22 | 13/05/22 | 12/08/22 | 10/11/22 | 14/08/23 | 14/11/23 |
| Today 16:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for CNS Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CNSP Stock
- Calendar CNS Pharmaceuticals, Inc.
